Cerba Lancet Nigeria Achieves New Heights with ISO 15189:2022 Accreditation
We are proud to announce our recent accreditation to the ISO 15189:2022 standard. This prestigious recognition demonstrates our laboratory's unwavering commitment to delivering high-quality patient care and exceptional laboratory services.
ISO 15189:2022 is an international standard that specifies the requirements for quality and competence in medical laboratories. This accreditation is a testament to Our dedication to maintaining the highest levels of technical competence, customer satisfaction, and continuous improvement.
"We are thrilled to achieve this milestone," said Dr. Olayemi Dawodu, MD/CEO of Cerba Lancet Nigeria. "Our team has worked tirelessly to ensure that our laboratory services meet the highest international standards. This accreditation is a reflection of our commitment to excellence and our passion for delivering exceptional patient care."
The ISO 15189:2022 accreditation process involved a rigorous evaluation of our quality management system, laboratory procedures, and technical competence. Our laboratory demonstrated its ability to consistently deliver accurate and reliable test results while maintaining a patient-centric approach.
Our state-of-the-art laboratory is equipped with cutting-edge technology and staffed by a team of experienced professionals. The laboratory offers a comprehensive range of diagnostic tests, including molecular diagnostics, cytology, and histopathology.
With this accreditation, we reinforce our position as a leader in the Nigerian healthcare industry. Patients and healthcare professionals can trust that our laboratory's services meet the highest international standards, ensuring accurate diagnoses and effective treatment.
